ArticleBreast cancer research : BCR2024

Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer.

Muriel Lainé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.